Phyllis K Stein1, Joshua I Barzilay. 1. Washington University School of Medicine, St. Louis, Missouri, USA. pstein@dom.wustl.edu
Abstract
INTRODUCTION: We examined whether heart rate turbulence (HRT) and C-reactive protein (CRP) add to traditional risk factors for cardiac mortality in older adults at low, intermediate, and high risk. METHODS AND RESULTS: One thousand two hundred and seventy-two individuals, age ≥ 65 years, with 24-hour Holter recordings were studied. HRT, which quantifies heart rate response to ventricular premature contractions, was categorized as: both turbulence onset (TO) and turbulence slope (TS) normal; TO abnormal; TS abnormal; or both abnormal. Independent risks for cardiac mortality associated with HRT or, for comparison, elevated CRP (>3.0 mg/L), were calculated using Cox regression analysis adjusted for traditional cardiovascular disease risk factors and stratified by the presence of no, isolated subclinical (i.e., intermediate risk) or clinical cardiovascular disease. Having TS + TO abnormal compared to both normal was associated with cardiac mortality in the low-risk group [HR 7.9, 95% confidence interval (CI) 2.8-22.5, (P < 0.001)]. In the high and intermediate risk groups, abnormal TS and TS + TO ([HR 2.2, 95% CI 1.5-4.0, P = 0.016] and [HR 2.7, 95% CI 1.2-5.9, P = 0.012]), respectively, were also significantly associated with cardiac mortality. In contrast, elevated CRP was associated with increased cardiac mortality risk only in low-risk individuals [HR 2.5, 95% CI 1.3-5.1, P = 0.009]. Among low risk, the c-statistic was 0.706 for the base model, 0.725 for the base model with CRP, and 0.767 for the base model with HRT. CONCLUSIONS: Abnormal HRT independently adds to risk stratification of low, intermediate and high-risk individuals, but HRT and CRP appear to both add to stratification of those considered low risk.
INTRODUCTION: We examined whether heart rate turbulence (HRT) and C-reactive protein (CRP) add to traditional risk factors for cardiac mortality in older adults at low, intermediate, and high risk. METHODS AND RESULTS: One thousand two hundred and seventy-two individuals, age ≥ 65 years, with 24-hour Holter recordings were studied. HRT, which quantifies heart rate response to ventricular premature contractions, was categorized as: both turbulence onset (TO) and turbulence slope (TS) normal; TO abnormal; TS abnormal; or both abnormal. Independent risks for cardiac mortality associated with HRT or, for comparison, elevated CRP (>3.0 mg/L), were calculated using Cox regression analysis adjusted for traditional cardiovascular disease risk factors and stratified by the presence of no, isolated subclinical (i.e., intermediate risk) or clinical cardiovascular disease. Having TS + TO abnormal compared to both normal was associated with cardiac mortality in the low-risk group [HR 7.9, 95% confidence interval (CI) 2.8-22.5, (P < 0.001)]. In the high and intermediate risk groups, abnormal TS and TS + TO ([HR 2.2, 95% CI 1.5-4.0, P = 0.016] and [HR 2.7, 95% CI 1.2-5.9, P = 0.012]), respectively, were also significantly associated with cardiac mortality. In contrast, elevated CRP was associated with increased cardiac mortality risk only in low-risk individuals [HR 2.5, 95% CI 1.3-5.1, P = 0.009]. Among low risk, the c-statistic was 0.706 for the base model, 0.725 for the base model with CRP, and 0.767 for the base model with HRT. CONCLUSIONS: Abnormal HRT independently adds to risk stratification of low, intermediate and high-risk individuals, but HRT and CRP appear to both add to stratification of those considered low risk.
Authors: G Schmidt; M Malik; P Barthel; R Schneider; K Ulm; L Rolnitzky; A J Camm; J T Bigger; A Schömig Journal: Lancet Date: 1999-04-24 Impact factor: 79.321
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: D G Ives; A L Fitzpatrick; D E Bild; B M Psaty; L H Kuller; P M Crowley; R G Cruise; S Theroux Journal: Ann Epidemiol Date: 1995-07 Impact factor: 3.797
Authors: Azad Ghuran; Fiona Reid; Maria Teresa La Rovere; Georg Schmidt; J Thomas Bigger; A John Camm; Peter J Schwartz; Marek Malik Journal: Am J Cardiol Date: 2002-01-15 Impact factor: 2.778
Authors: John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason Journal: N Engl J Med Date: 2004-04-01 Impact factor: 91.245
Authors: L Kuller; N Borhani; C Furberg; J Gardin; T Manolio; D O'Leary; B Psaty; J Robbins Journal: Am J Epidemiol Date: 1994-06-15 Impact factor: 4.897
Authors: B M Psaty; L H Kuller; D Bild; G L Burke; S J Kittner; M Mittelmark; T R Price; P M Rautaharju; J Robbins Journal: Ann Epidemiol Date: 1995-07 Impact factor: 3.797
Authors: Erin B Wasserman; Wojciech Zareba; Mark J Utell; David Oakes; Philip K Hopke; Mark Frampton; David Chalupa; William Beckett; David Q Rich Journal: Air Qual Atmos Health Date: 2014-09-01 Impact factor: 3.763
Authors: Bonnie E Legg Ditterline; Sevda C Aslan; David C Randall; Susan J Harkema; Camilo Castillo; Alexander V Ovechkin Journal: Arch Phys Med Rehabil Date: 2017-08-09 Impact factor: 3.966
Authors: Erin Foran Wolff; Yunxiao He; Dennis M Black; Eliot A Brinton; Mathew J Budoff; Marcelle I Cedars; Howard N Hodis; Rogerio A Lobo; Joann E Manson; George R Merriam; Virginia M Miller; Fredrick Naftolin; Lubna Pal; Nanette Santoro; Heping Zhang; S Mitchell Harman; Hugh S Taylor Journal: Fertil Steril Date: 2013-01-08 Impact factor: 7.329
Authors: Bonnie E Legg Ditterline; Sevda C Asian; David C Randall; Susan J Harkema; Camilo Castillo; Alexander V Ovechkin Journal: Arch Phys Med Rehabil Date: 2018-04 Impact factor: 3.966
Authors: Anne Kastelianne França da Silva; Marianne Penachini da Costa de Rezende Barbosa; Franciele Marques Vanderlei; Diego Giuliano Destro Christofaro; Luiz Carlos Marques Vanderlei Journal: Ann Noninvasive Electrocardiol Date: 2016-05 Impact factor: 1.468